Medtronic Rolls Out New Miniature Heart Monitor

After receiving the necessary regulatory approval, Medtronic (NYSE: MDT  ) is launching its latest product on the global market. The medical devices company announced on Wednesday that it has received clearance from the U.S. Food and Drug Administration and the European Union for its Reveal LINQ Insertable Cardiac Monitor System, which is now available for purchase.

Medtronic said in a press release that the Reveal LINQ ICM is the smallest implantable cardiac monitoring device on the market, roughly 80% smaller than competing devices. It allows doctors to remotely monitor a patient's heart for up to three years.

The news comes on the heels of the company's third-quarter earnings release. Although quarterly revenue rose 3.4% on a year-over-year basis to $4.16 billion, net income dropped by nearly the same percentage to land at $916 million ($0.91 per share).


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2845636, ~/Articles/ArticleHandler.aspx, 7/29/2014 4:54:31 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement